100
Participants
Start Date
January 10, 2024
Primary Completion Date
September 17, 2024
Study Completion Date
October 10, 2024
Pantoprazole
Subjects will receive pantoprazole (40 mg iv q12H) for 2 days perioperatively (first dose after anesthesia induction and before surgical incision, second dose at chest closure, then followed by 2 doses daily (Q12hr dosing) on post operative day 1 (POD 1) for a total of 4 doses over 2 days.
Famotidine
Subjects will receive famotidine (20 mg iv q12H) for 2 days perioperatively (first dose after anesthesia induction and before surgical incision, second dose at chest closure, then followed by 2 doses daily (Q12hr dosing) on POD 1 for a total of 4 doses over 2 days.
The University of Texas Health Science Center at Houston, Houston
Society of Cardiovascular Anesthesiologists
UNKNOWN
The University of Texas Health Science Center, Houston
OTHER